Parallel group RCTs are considered the gold standard in clinical research because they help to minimize bias and confounding factors. Randomization ensures that each group is comparable at baseline, which allows for a more accurate assessment of the intervention's effect. This design is ideal for evaluating the efficacy of new treatments, drugs, or preventive measures.
